IP Library Granted Patent US 8,110,364
Granted Patent B2
US 8,110,364 · App. 12/958,344 · Granted Feb 7, 2012

Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,110,364
App. No.
12/958,344
Granted
Feb 7, 2012
Kind
B2
Abstract

Methods of diagnosing or monitoring an autoimmune or chronic inflammatory disease, particularly SLE in a patient by detecting the expression level of one or more genes or surrogates derived therefrom in the patient are described. Diagnostic oligonucleotides for diagnosing or monitoring chronic inflammatory disease, particularly SLE infection and kits or systems containing the same are also described.

Claims (8)

1. A method of diagnosing or monitoring an autoimmune or chronic inflammatory disease in a patient, comprising detecting the expression level of a nucleic acid in said patient to diagnose or monitor said autoimmune or chronic inflammatory disease in said patient wherein said nucleic acid comprises the nucleotide sequence SEQ ID NO: 3305.

2. The method of claim 1 wherein said autoimmune or chronic inflammatory disease is systemic lupus erythematosis (SLE).

3. The method of claim 1 wherein said expression level is detected by measuring the RNA level expressed by said nucleic acid.

4. The method of claim 3 , further comprising isolating RNA from said patient prior to detecting said RNA level expressed by said nucleic acid.

5. The method of claim 3 wherein said RNA level is detected by PCR.

6. The method of claim 3 wherein said RNA level is detected by hybridization.

7. The method of claim 3 wherein said RNA level is detected by hybridization to an oligonucleotide.

8. The method of claim 7 wherein said oligonucleotide comprises DNA, RNA, cDNA, PNA, genomic DNA, or synthetic oligonucleotides.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING DATA AND RECEIVING DATA PREVIOUSLY RECORDED AT REEL: 047795 FRAME: 0361. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST IN PATENTS. Recorded Dec 18, 2018
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: CAREDX, INC.
Reel/Frame 047950/0647 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED AT REEL: 047731 FRAME: 0947. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Dec 12, 2018
From: CAREDX, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 047795/0361 →
RELEASE OF SECURITY INTEREST Recorded Dec 10, 2018
From: CAREDX, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 047731/0947 →
SECURITY AGREEMENT Recorded Apr 18, 2018
From: CAREDX, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 045781/0128 →
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2018
From: JGB COLLATERAL, LLC
To: CAREDX, INC.
Reel/Frame 045398/0036 →
RELEASE OF SECURITY INTEREST Recorded Mar 28, 2017
From: EAST WEST BANK
To: CAREDX, INC.
Reel/Frame 041771/0524 →
SECURITY INTEREST Recorded Mar 22, 2017
From: CAREDX, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 041681/0307 →